Ko, Soo Sung et al. published their patent in 2014 |CAS: 1261475-16-4

The Article related to carbazolecarboxamide preparation bruton tyrosine kinase btk kinase inhibitor, phenylcarbazolecarboxamide preparation kinase inhibitor, autoimmune disease chronic inflammatory disease treatment prevention phenylcarbazolecarboxamide preparation and other aspects.Recommanded Product: 1-Bromo-3-isocyanato-2-methyl-benzene

On December 31, 2014, Ko, Soo Sung; Batt, Douglas A.; Bertrand, Myra Beaudoin; Delucca, George V.; Langevine, Charles M.; Liu, Qingjie; Srivastava, Anurag S.; Watterson, Scott Hunter published a patent.Recommanded Product: 1-Bromo-3-isocyanato-2-methyl-benzene The title of the patent was Preparation of 4-phenylcarbazole-1-carboxamide compounds useful as Bruton’s tyrosine kinase (Btk) inhibitors. And the patent contained the following:

There are disclosed carbazolecarboxamide compounds of formula [I; Q = Q1, Q2, Q3, or Q4; R1 = C(CH3)2OH, NHC(O)C(CH3)3, N(CH3)2, or CH2Rd; R2 = Cl or CH3; R3 = H, F, or CH3; Ra = H or CH3; Rb = H, F, Cl, or OCH3; Rc = H or F; Rd = OH, OCH3, NHC(O)CH3, or pyrrolidin-1-yl] or salts thereof. These compounds are inhibitors of kinases, in particular Bruton’s tyrosine kinase (Btk) and are useful in treating, preventing, or slowing the progression of diseases or disorders in a variety of therapeutic areas, such as autoimmune diseases and chronic inflammatory diseases. Thus, 4-bromo-7-(2-hydroxypropan-2-yl)-9H-carbazole-1-carboxamide was coupled with 5-chloro-2-[2-methyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-1H-pyrido[1,2-c]pyrimidine-1,3(2H)-dione in the presence of Pd2(dppf).CH2Cl2adduct and Cs2CO3 in THF under argon at 45° for 3.5 h to give 39% 4-[3-(5-chloro-1,3-dioxo-1H-pyrido[1,2-c]pyrimidin-2(3H)-yl)-2-methylphenyl]-7-(2-hydroxypropan-2-yl)-9H-carbazole-1-carboxamide as a mixture of 4 diastereomers which was separated by chiral super-critical fluid chromatog. to give 4-[3-(R)-(5-Chloro-1,3-dioxo-1H-pyrido[1,2-c]pyrimidin-2(3H)-yl)-2-methylphenyl]-7-(2-hydroxypropan-2-yl)-9H-carbazole-1-carboxamide (II) and 4-[3-(S)-(5-chloro-1,3-dioxo-1H-pyrido[1,2-c]pyrimidin-2(3H)-yl)-2-methylphenyl]-7-(2-hydroxypropan-2-yl)-9H-carbazole-1-carboxamide (III). III showed IC50 of 0.41 and 1,000 nM against human recombinant Bruton’s tyrosine kinase (Btk) and Jak2 tyrosine kinase, resp. The experimental process involved the reaction of 1-Bromo-3-isocyanato-2-methyl-benzene(cas: 1261475-16-4).Recommanded Product: 1-Bromo-3-isocyanato-2-methyl-benzene

The Article related to carbazolecarboxamide preparation bruton tyrosine kinase btk kinase inhibitor, phenylcarbazolecarboxamide preparation kinase inhibitor, autoimmune disease chronic inflammatory disease treatment prevention phenylcarbazolecarboxamide preparation and other aspects.Recommanded Product: 1-Bromo-3-isocyanato-2-methyl-benzene

Referemce:
Bromide – Wikipedia,
bromide – Wiktionary

Watanabe, Hideyuki et al. published their patent in 2022 |CAS: 1805937-67-0

The Article related to antibody immunotherapy resistant cancer treatment, heteroaryl carboxamide preparation dgkzeta inhibitor anticancer, phenylpyrazolecarboxamide phenyloxodihydropyridinecarboxamide phenyloxazolecarboxamide preparation dgkzeta inhibitor anticancer and other aspects.Electric Literature of 1805937-67-0

On June 2, 2022, Watanabe, Hideyuki; Kamikubo, Takashi; Kamikawa, Akio; Washio, Takuya; Seki, Yohei; Okuyama, Keiichiro; Ikeda, Osamu; Tomiyama, Hiroshi; Iwai, Yoshinori; Nakamura, Akihiko; Miyasaka, Kozo published a patent.Electric Literature of 1805937-67-0 The title of the patent was Preparation of heteroaryl carboxamide compounds as DGKζ (DGKzeta) inhibitors and anticancer agents. And the patent contained the following:

Heteroaryl carboxamide compounds including N-phenyl-1H-pyrazole-3-carboxamides, N-phenyl-2-oxo-1,2-dihydropyridine-3-carboxamides, and N-phenyloxazole-4-carboxamides represented by formula I [A = Q1, Q2, Q3, or Q4; B = Q5, Q6, Q7, or Q8; when R1 a = halo-C1-6 alkyl, B = Q5; R1a = pyridazinyl or halo-C1-6 alkyl; R1b = H or C1-6 alkyl; R2 = C3-5 cycloalkyl, C1-6 alkyloxy, halo-C1-6 alkyl, halo, or Ph; R3 = each (un)substituted Ph, C3-8 cycloalkyl, or pyridyl, or 5- or 6-membered partially unsaturated heterocyclyl containing 1-4 heteroatoms selected from O, S, and N atoms; R4 = H or F; R6 = -L2-(CH2)2NRaRb, or piperidinyl; L1 = a singe bond, O, or NH; L2 = a single bond, O, or CH2; X = CH2 or NMe; Y = CH or N; Ra = H or Me; Rb = H, Me, Et, cyclopropyl, or (CH2)2OMe; m = 1, 2, or 3] or salts thereof are prepared The compounds I or salts thereof have a DGKζ (DGKzeta) inhibiting activity and are useful as active ingredients for pharmaceutical compositions for treating cancer associated with the activation of an immunocyte or cancer having resistance to an anti-PD-1 antibody/anti-PD-L1 antibody therapy. Thus, [[(2R)-4-[6-amino-3-(2-fluorophenoxy)-2-(trifluoromethyl)phenyl]-1-methylpiperazin-2-yl]methyl](methyl)carbamic acid tert-Bu ester was condensed with 1-(pyridazin-4-yl)-1H-pyrazole-3-carboxylic acid using HATU in the presence of diisopropylethylamine in DMF at 50° for 12 h to give [[(2R)-4-[3-(2-fluorophenoxy)-6-[[[1-(pyridazin-4-yl)-1H-pyrazol-3-yl]carbonyl]amino]-2-(trifluoromethyl)phenyl]-1-methylpiperazin-2-yl]methyl](methyl)carbamic acid tert-Bu ester which was treated with CF3CO2H in CH2Cl2 at room temperature for 4 h followed by purification using silica gel chromatog. (CHCl3/MeOH/aqueous ammonia solution) to give N-[4-(2-fluorophenoxy)-2-[(3S)-4-methyl-3-[(methylamino)methyl]piperazin-1-yl]-3-(trifluoromethyl)phenyl]-1-(pyridazin-4-yl)-1H-pyrazole-3-carboxamide (II). II, II monobutanedioate, and compound (III) showed IC50 of 10, 3.2, 0.42 nM, resp., against human recombinant DGKζ (DGKzeta). The experimental process involved the reaction of 2-Bromo-4-fluoro-1-nitro-3-(trifluoromethyl)benzene(cas: 1805937-67-0).Electric Literature of 1805937-67-0

The Article related to antibody immunotherapy resistant cancer treatment, heteroaryl carboxamide preparation dgkzeta inhibitor anticancer, phenylpyrazolecarboxamide phenyloxodihydropyridinecarboxamide phenyloxazolecarboxamide preparation dgkzeta inhibitor anticancer and other aspects.Electric Literature of 1805937-67-0

Referemce:
Bromide – Wikipedia,
bromide – Wiktionary

Huang, Ming-Yao et al. published their research in Angewandte Chemie, International Edition in 2022 |CAS: 2567-29-5

The Article related to regioselective stereoselective enantioselective copper catalyst insertion silylcarbene mechanism, crystal structure mol allylic silyl borane preparation chiral, asymmetric catalysis, b−h bond insertion, carbenes, copper catalysis, cyclopropenes and other aspects.Recommanded Product: 4-(Bromomethyl)-1,1′-biphenyl

On June 27, 2022, Huang, Ming-Yao; Zhao, Yu-Tao; Zhang, Cheng-Da; Zhu, Shou-Fei published an article.Recommanded Product: 4-(Bromomethyl)-1,1′-biphenyl The title of the article was Highly Regio-, Stereo-, and Enantioselective Copper-Catalyzed B-H Bond Insertion of α-Silylcarbenes: Efficient Access to Chiral Allylic gem-Silylboranes. And the article contained the following:

Herein, we report the development of a method for highly regio-, stereo-, and enantioselective B-H bond insertion reactions of α-silylcarbenes generated from 1-silylcyclopropenes in the presence of a chiral copper(I)/bisoxazoline catalyst for the construction of chiral γ,γ-disubstituted allylic gem-silylboranes, which cannot be prepared by any other known methods. This reaction is the first highly enantioselective carbene insertion reaction of α-silylcarbenes ever to be reported. The method shows general applicability for various 3,3-disubstituted silylcyclopropenes and exclusively affords E-products. The novel chiral γ,γ-disubstituted allylic gem-silylborane products are versatile allylic bimetallic reagents with high stability and have great synthetic potential, especially for the construction of complex mols. with continuous chiral centers. The experimental process involved the reaction of 4-(Bromomethyl)-1,1′-biphenyl(cas: 2567-29-5).Recommanded Product: 4-(Bromomethyl)-1,1′-biphenyl

The Article related to regioselective stereoselective enantioselective copper catalyst insertion silylcarbene mechanism, crystal structure mol allylic silyl borane preparation chiral, asymmetric catalysis, b−h bond insertion, carbenes, copper catalysis, cyclopropenes and other aspects.Recommanded Product: 4-(Bromomethyl)-1,1′-biphenyl

Referemce:
Bromide – Wikipedia,
bromide – Wiktionary

Zhang, Rongyi et al. published their research in Chemistry – A European Journal in 2021 |CAS: 2567-29-5

The Article related to halogenated acyclic difluoromethyl ether thioether preparation, cyclic ether trimethylsilyl difluoromethyl halide ring opening difluoromethylation halogenation, difluorocarbene, difluoromethyl ether, orthogonal synthesis, oxonium ylide, ring-opening and other aspects.Related Products of 2567-29-5

On December 20, 2021, Zhang, Rongyi; Li, Qigang; Xie, Qiqiang; Ni, Chuanfa; Hu, Jinbo published an article.Related Products of 2567-29-5 The title of the article was Difluorocarbene-Induced Ring-Opening Difluoromethylation-Halogenation of Cyclic (Thio)Ethers with TMSCF2X (X=Br, Cl). And the article contained the following:

The ring-opening difluoromethylation-halogenation of cyclic (thio)ethers is reported through a simple strategy relying on carbon-chalcogen bond activation with difluorocarbene. The reaction proceeds through in situ protonation of the previously little-known difluoromethylene oxonium or sulfonium ylide intermediate followed by ring-opening with halide ion to afford halogenated acyclic difluoromethyl (thio)ethers that can then be employed for further elaboration. TMSCF2X (X=Br, Cl) are unique reagents to achieve this synthetic purpose, which serve as both the difluorocarbene source and the halide ion source. The experimental process involved the reaction of 4-(Bromomethyl)-1,1′-biphenyl(cas: 2567-29-5).Related Products of 2567-29-5

The Article related to halogenated acyclic difluoromethyl ether thioether preparation, cyclic ether trimethylsilyl difluoromethyl halide ring opening difluoromethylation halogenation, difluorocarbene, difluoromethyl ether, orthogonal synthesis, oxonium ylide, ring-opening and other aspects.Related Products of 2567-29-5

Referemce:
Bromide – Wikipedia,
bromide – Wiktionary

Wang, Jixin et al. published their research in Angewandte Chemie, International Edition in 2022 |CAS: 2567-29-5

The Article related to silylzinc pivalate preparation reactivity nickel catalyzed carbosilylation alkene, organosilane preparation, silyllithium reagent transmetalation zinc pivalate, alkene difunctionalizations, carbosilylation, cross-coupling, nickel, silylzinc pivalates and other aspects.Name: 4-(Bromomethyl)-1,1′-biphenyl

On April 19, 2022, Wang, Jixin; Duan, Zhili; Liu, Xingchen; Dong, Shoucheng; Chen, Kaixin; Li, Jie published an article.Name: 4-(Bromomethyl)-1,1′-biphenyl The title of the article was Salt-Stabilized Silylzinc Pivalates for Nickel-Catalyzed Carbosilylation of Alkenes. And the article contained the following:

The authors herein report the preparation of solid and salt-stabilized silylzinc pivalates from the corresponding silyllithium reagents via transmetalation with Zn(OPiv)2. These resulting organosilylzinc pivalates show enhanced air and moisture stability and unique reactivity in the silylative difunctionalization of alkenes. Thus, a practical chelation-assisted Ni-catalyzed regioselective alkyl and benzylsilylation of alkenes was developed, which provides an easy method to access alkyl silanes with broad substrate scope and wide functional group compatibility. Kinetic experiments highlight that the OPiv-coordination is crucial to improve the reactivity of silylzinc pivalates. Also, late-stage functionalizations of druglike mols. and versatile modifications of the products illustrate the synthetical utility of this protocol. The experimental process involved the reaction of 4-(Bromomethyl)-1,1′-biphenyl(cas: 2567-29-5).Name: 4-(Bromomethyl)-1,1′-biphenyl

The Article related to silylzinc pivalate preparation reactivity nickel catalyzed carbosilylation alkene, organosilane preparation, silyllithium reagent transmetalation zinc pivalate, alkene difunctionalizations, carbosilylation, cross-coupling, nickel, silylzinc pivalates and other aspects.Name: 4-(Bromomethyl)-1,1′-biphenyl

Referemce:
Bromide – Wikipedia,
bromide – Wiktionary

Rezaei, Mohammad Taher et al. published their research in Journal of Molecular Structure in 2021 |CAS: 574-98-1

The Article related to preparation manganese cadmium zinc scorpionate complex, crystal mol structure manganese cadmium zinc scorpionate complex, mol docking manganese cadmium zinc scorpionate complex, anticancer antioxidant activity manganese cadmium zinc scorpionate complex and other aspects.Category: bromides-buliding-blocks

On January 15, 2021, Rezaei, Mohammad Taher; Keypour, Hassan; Bayat, Mehdi; Soltani, Elham; Jamshidi, Mahdi; Gable, Robert William published an article.Category: bromides-buliding-blocks The title of the article was Synthesis of a tertiary amine by direct reductive amination of a carbonyl compound to form a scorpionate ligand; formation of Mn (II), Zn (II) and Cd (II) complexes, DFT calculations and, molecular docking studies. And the article contained the following:

A hexadentate, asym. tripodal scorpionate type ligand, [[N1-Pyridin-2-ylmethyl-N1-[2-(4-pyridine-2-ylmethyl-piperazine-1-yl)-ethyl]-ethane-1,2-diamine]] (L) was prepared To form this ligand, the direct reductive amination of a carbonyl compound by NaBH4 was used for the synthesis of tertiary amine. The complexes [MnL](ClO4)2, [CdL](ClO4)2, [ZnL](ClO4)2 also were prepared The synthesized compounds were characterized by elemental analyses, FTIR, ESI-MS and, NMR spectroscopy. An X-ray crystal structure of [MnL] (ClO4)2, shows that the coordination environment around the manganese is a distorted trigonal prism. The nature of metal-ligand bonding in the complexes was studied by Natural Bond Orbital anal., Energy Decomposition Anal. and Energy Decomposition Anal. using Natural Orbitals for Chem. Valence variation. Mol. docking was used for the biol. evaluation of the anticancer and antioxidant activities of the synthesized compounds The docking results indicated that the Cd, Mn, and Zn-complexes had the highest binding affinity (MolDock Score) for the binding sites of cytochrome P 450, myeloperoxidase, and cytochrome P 450, resp. The experimental process involved the reaction of 2-(2-Bromoethyl)isoindoline-1,3-dione(cas: 574-98-1).Category: bromides-buliding-blocks

The Article related to preparation manganese cadmium zinc scorpionate complex, crystal mol structure manganese cadmium zinc scorpionate complex, mol docking manganese cadmium zinc scorpionate complex, anticancer antioxidant activity manganese cadmium zinc scorpionate complex and other aspects.Category: bromides-buliding-blocks

Referemce:
Bromide – Wikipedia,
bromide – Wiktionary

Wang, Qian et al. published their research in Angewandte Chemie, International Edition in 2021 |CAS: 2567-29-5

The Article related to electrophile fluorination fluoroalkylation dibromo bistrifluoromethylethylene magnetic resonance imaging safety, perfluoro tert butylated compound preparation, fluorination, fluoroalkylation, imaging probes, magnetic resonance imaging, perfluoro-tert-butylation and other aspects.Related Products of 2567-29-5

On December 20, 2021, Wang, Qian; Tao, Quan; Dong, Hui; Ni, Chuanfa; Xie, Xiaoming; Hu, Jinbo published an article.Related Products of 2567-29-5 The title of the article was Fluorination Triggers Fluoroalkylation: Nucleophilic Perfluoro-tert-butylation with 1,1-Dibromo-2,2-bis(trifluoromethyl)ethylene (DBBF) and CsF. And the article contained the following:

Perfluoro-tert-butylation reaction has long remained a challenging task. We now report the use of 1,1-dibromo-2,2-bis(trifluoromethyl)ethylene (DBBF, I) as a practical reagent for perfluoro-tert-butylation reactions for the first time. Through a consecutive triple-fluorination process with DBBF and CsF, the (CF3)3C- species can be liberated and observed, which is able to serve as a robust nucleophilic perfluoro-tert-butylating agent for various electrophiles. The power of this synthetic protocol is evidenced by the efficient synthesis of structurally diverse perfluoro-tert-butylated mols. Multiple applications demonstrate the practicability of this method, as well as the superiority of perfluoro-tert-butylated compounds as sensitive probes. The perfluoro-tert-butylated product was successfully applied in 1H- and 19F-magnetic resonance imaging (MRI) experiment with an ultra-low field (ULF) MRI system. The experimental process involved the reaction of 4-(Bromomethyl)-1,1′-biphenyl(cas: 2567-29-5).Related Products of 2567-29-5

The Article related to electrophile fluorination fluoroalkylation dibromo bistrifluoromethylethylene magnetic resonance imaging safety, perfluoro tert butylated compound preparation, fluorination, fluoroalkylation, imaging probes, magnetic resonance imaging, perfluoro-tert-butylation and other aspects.Related Products of 2567-29-5

Referemce:
Bromide – Wikipedia,
bromide – Wiktionary

Zhang, Liangliang et al. published their research in Inorganic Chemistry Communications in 2012 |CAS: 41819-13-0

The Article related to lanthanide bromobenzenetetracarboxylate oxalate 3d framework complex hydrothermal preparation, crystal structure lanthanide bromobenzenetetracarboxylate oxalate 3d framework complex, luminescence lanthanide bromobenzenetetracarboxylate oxalate 3d framework complex and other aspects.Formula: C10H4Br2O8

On December 31, 2012, Zhang, Liangliang; Guo, Jie; Meng, Qingguo; Pang, Haiduo; Chen, Zhen; Sun, Daofeng published an article.Formula: C10H4Br2O8 The title of the article was Two novel isostructural Ln(III) 3D frameworks supported by 3,6-dibromobenzene-1,2,4,5-tetracarboxylic acid and in situ generated oxalate: Syntheses, characterization and photoluminescent property. And the article contained the following:

Two isostructural lanthanide complexes, [Ln(dbtec)0.5(ox)0.5·3H2O]n, [Ln = Dy (1), Yb (2)] (H4dbtec = 3,6-dibromobenzene-1,2,4,5-tetracarboxylic acid; H2ox = oxalic acid), were synthesized under the hydrothermal method and characterized by single-crystal x-ray diffraction, X-ray powder diffraction (PXRD), TGA and elemental anal. (EA) and IR spectra. Complexes 1 and 2 present a 2-nodal (4,6)-connected 3-dimensional fsc network. The 13C NMR of H4dbtec indicates ox in 1 and 2 is generated by the in situ decomposition of H4dbtec. Addnl., the photoluminescent properties of 1 and 2 are also discussed. The experimental process involved the reaction of 3,6-Dibromobenzene-1,2,4,5-tetracarboxylic acid(cas: 41819-13-0).Formula: C10H4Br2O8

The Article related to lanthanide bromobenzenetetracarboxylate oxalate 3d framework complex hydrothermal preparation, crystal structure lanthanide bromobenzenetetracarboxylate oxalate 3d framework complex, luminescence lanthanide bromobenzenetetracarboxylate oxalate 3d framework complex and other aspects.Formula: C10H4Br2O8

Referemce:
Bromide – Wikipedia,
bromide – Wiktionary

Li, Shichao et al. published their research in Chemical Communications (Cambridge, United Kingdom) in 2022 |CAS: 2567-29-5

The Article related to palladium catalyzed coupling benzyl bromide bmida nitrogen tosylhydrazone, trans alkenyl mida boronate preparation, methyliminodiacetyl boronate palladium catalyzed stereoselective reaction benzyl bromide, alkenyl methyliminodiacetyl boronate stereoselective synthesis and other aspects.Electric Literature of 2567-29-5

Li, Shichao; Li, Muyao; Li, Shu-Sen; Wang, Jianbo published an article in 2022, the title of the article was Pd-Catalyzed coupling of benzyl bromides with BMIDA-substituted N-tosylhydrazones: synthesis of trans-alkenyl MIDA boronates.Electric Literature of 2567-29-5 And the article contains the following content:

A palladium-catalyzed stereoselective synthesis of alkenyl boronates from N-methyliminodiacetyl boronate (BMIDA)-substituted N-tosylhydrazone and benzyl bromides is developed. A range of trans-alkenyl MIDA boronates as single stereoisomers were obtained in moderate yields with good functional group compatibility. The resultant boronate products may be transformed to other boron-containing compounds and may also be directly used in cross-coupling reactions. The experimental process involved the reaction of 4-(Bromomethyl)-1,1′-biphenyl(cas: 2567-29-5).Electric Literature of 2567-29-5

The Article related to palladium catalyzed coupling benzyl bromide bmida nitrogen tosylhydrazone, trans alkenyl mida boronate preparation, methyliminodiacetyl boronate palladium catalyzed stereoselective reaction benzyl bromide, alkenyl methyliminodiacetyl boronate stereoselective synthesis and other aspects.Electric Literature of 2567-29-5

Referemce:
Bromide – Wikipedia,
bromide – Wiktionary

Zuo, Ziqing team published research in Journal of the American Chemical Society in 2021 | 20469-65-2

Safety of 1-Bromo-3,5-dimethoxybenzene, 1-Bromo-3,5-dimethoxybenzene, also known as 1-Bromo-3,5-dimethoxybenzene, is a useful research compound. Its molecular formula is C8H9BrO2 and its molecular weight is 217.06 g/mol. The purity is usually 95%.
1-Bromo-3,5-dimethoxybenzene is used as an intermediate in the synthetic preparation of pharmaceutical inhibitors via cross-coupling reactions.
1-Bromo-3,5-dimethoxybenzene can be synthesized by using 1,3-dimethoxybenzene via iridium-catalyzed arene borylation.
1-Bromo-3,5-dimethoxybenzene (1BDMB) is a synthetic molecule that can be used as an electron acceptor in organic photovoltaic cells. 1BDMB is a salt of the sodium salt of resorcylic acid and 1,3-dibromo-5,5-dimethoxybenzene. It has been shown to have a radical mechanism for the generation of free radicals. The radical mechanism is initiated by light absorption by the ruthenium complex at the center of the molecule which induces photoinduced electron transfer from the ruthenium to 1BDMB. This process results in electron transfer from the donor to an acceptor molecule, such as oxygen or nitrogen. The pharmacokinetic properties of this compound are not well known; however, it has been demonstrated that it can be synthesized through a cross-coupling reaction with other aromatic compounds such as stemofuran., 20469-65-2.

One prominent application of synthetic organobromine compounds is the use of polybrominated diphenyl ethers as fire-retardants, and in fact fire-retardant manufacture is currently the major industrial use of the element bromine. 20469-65-2, formula is C8H9BrO2, Name is 1-Bromo-3,5-dimethoxybenzene, Safety of 1-Bromo-3,5-dimethoxybenzene

Zuo, Ziqing;Kim, Raphael S.;Watson, Donald A. research published 《 Synthesis of Axially Chiral 2,2′-Bisphosphobiarenes via a Nickel-Catalyzed Asymmetric Ullmann Coupling: General Access to Privileged Chiral Ligands without Optical Resolution》, the research content is summarized as follows. The authors report an asym. homocoupling of ortho-(iodo)arylphosphine oxides and ortho-(iodo)arylphosphonates resulting in highly enantioenriched axially chiral bisphosphine oxides and bisphosphonates. These products are readily converted to enantioenriched biaryl bisphosphines without need for chiral auxiliaries or optical resolution This provides a practical route for the development of previously unstudied atroposelective biaryl bisphosphine ligands. The conditions also proved effective for asym. dimerization of other, nonphosphorus-containing aryl halides.

Safety of 1-Bromo-3,5-dimethoxybenzene, 1-Bromo-3,5-dimethoxybenzene, also known as 1-Bromo-3,5-dimethoxybenzene, is a useful research compound. Its molecular formula is C8H9BrO2 and its molecular weight is 217.06 g/mol. The purity is usually 95%.
1-Bromo-3,5-dimethoxybenzene is used as an intermediate in the synthetic preparation of pharmaceutical inhibitors via cross-coupling reactions.
1-Bromo-3,5-dimethoxybenzene can be synthesized by using 1,3-dimethoxybenzene via iridium-catalyzed arene borylation.
1-Bromo-3,5-dimethoxybenzene (1BDMB) is a synthetic molecule that can be used as an electron acceptor in organic photovoltaic cells. 1BDMB is a salt of the sodium salt of resorcylic acid and 1,3-dibromo-5,5-dimethoxybenzene. It has been shown to have a radical mechanism for the generation of free radicals. The radical mechanism is initiated by light absorption by the ruthenium complex at the center of the molecule which induces photoinduced electron transfer from the ruthenium to 1BDMB. This process results in electron transfer from the donor to an acceptor molecule, such as oxygen or nitrogen. The pharmacokinetic properties of this compound are not well known; however, it has been demonstrated that it can be synthesized through a cross-coupling reaction with other aromatic compounds such as stemofuran., 20469-65-2.

Referemce:
Bromide – Wikipedia,
bromide – Wiktionary